Likewise’s Tony Brewer on accelerating growth, strong investment and £200m+ revenue ambition 4 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP 4 February 2026
Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum 2 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
Goodwin PLC (GDWN.L) Investor Outlook: Robust Revenue Growth and Strategic Market Positioning 24 February 2026
Chemring Group PLC (CHG.L) Stock Analysis: Exploring a 21.57% Potential Upside for Aerospace & Defense Investors 24 February 2026
Bankers Investment Trust PLC (BNKR.L): Analyzing a Robust 502% Revenue Growth Amidst Market Dynamics 24 February 2026
Auction Technology Group PLC (ATG.L): An Investor’s Insight into Its 66% Potential Upside 24 February 2026
Likewise’s Tony Brewer on accelerating growth, strong investment and £200m+ revenue ambition 4 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP 4 February 2026
Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum 2 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
Goodwin PLC (GDWN.L) Investor Outlook: Robust Revenue Growth and Strategic Market Positioning 24 February 2026
Chemring Group PLC (CHG.L) Stock Analysis: Exploring a 21.57% Potential Upside for Aerospace & Defense Investors 24 February 2026
Bankers Investment Trust PLC (BNKR.L): Analyzing a Robust 502% Revenue Growth Amidst Market Dynamics 24 February 2026
Auction Technology Group PLC (ATG.L): An Investor’s Insight into Its 66% Potential Upside 24 February 2026
Establishment Labs Holdings Inc (ESTA) Stock Analysis: Healthcare Innovator with 11% Upside Potential 24 February 2026
Astrana Health Inc. (ASTH) Stock Analysis: A Healthcare Gem with Nearly 80% Upside Potential 24 February 2026
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Target Price Suggests 26.84% Upside for Biotech Innovator 24 February 2026
Harmony Biosciences Holdings (HRMY) Stock Analysis: Positioned for a 70% Upside in Biotech Sector 24 February 2026
Kiniksa Pharmaceuticals (KNSA) Stock Analysis: A Biopharma’s Strong Growth Trajectory and 17.9% Upside Potential 24 February 2026
Centessa Pharmaceuticals (CNTA) Stock Analysis: Significant Upside with a 55.42% Potential 24 February 2026
Xenon Pharmaceuticals Inc. (XENE) Investor Outlook: Analyzing a 30% Potential Upside with Strong Buy Ratings 24 February 2026
Brookdale Senior Living Inc. (BKD) Stock Analysis: Strong Analyst Buy Ratings and 25.49% Potential Upside 24 February 2026
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 14.60% Potential Upside 24 February 2026
Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook Highlights 21% Potential Upside 24 February 2026
PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 24.21% Potential Upside in the Biotech Sector 24 February 2026
Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a Promising 8.92% Potential Upside 24 February 2026
Surgery Partners, Inc. (SGRY): Growth Potential with a 64% Upside and Strong Buy Ratings 24 February 2026
Ocular Therapeutix, Inc. (OCUL) Investor Outlook: A Biotech with a 205% Potential Upside 24 February 2026
Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Promising Biotech with Nearly 50% Upside Potential 24 February 2026
Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 33% Potential Upside in Diagnostics Innovation 24 February 2026
Innoviva, Inc. (INVA) Stock Analysis: Exploring a 40.97% Potential Upside for Investors 24 February 2026
Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a 72.96% Potential Upside in the Biotech Innovator 24 February 2026
Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Ruffer Investment Company: Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
RM plc Unlocking the Future of Global Assessment with Scalable AI and Digital Exams (Video) 21 January 2026
Likewise’s Tony Brewer on accelerating growth, strong investment and £200m+ revenue ambition 4 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP 4 February 2026
Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum 2 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Goodwin PLC (GDWN.L) Investor Outlook: Robust Revenue Growth and Strategic Market Positioning 24 February 2026
Chemring Group PLC (CHG.L) Stock Analysis: Exploring a 21.57% Potential Upside for Aerospace & Defense Investors 24 February 2026
Bankers Investment Trust PLC (BNKR.L): Analyzing a Robust 502% Revenue Growth Amidst Market Dynamics 24 February 2026
Auction Technology Group PLC (ATG.L): An Investor’s Insight into Its 66% Potential Upside 24 February 2026
